prod:prod_dcx-login
Xpert HCV® Viral Load
Highly sensitive, timely results to support patient management
Para ver los precios, inicie sesión o cree una cuenta de MyCepheid
Número de ensayos
10 Pruebas
GXHCV-VL-CE-10
Cant.
Precio por unidad
Subtotal
USD
El producto no está disponible para la compra en su región.
Total
{{currency}}
0
Error al añadir los artículos a la cesta. Si este error persiste, póngase en contacto con Soporte digital.
La necesidad
- Measurement of blood plasma HCV RNA using PCR is established as the standard of care in assessing HCV treatment and prognosis.
- Highly-sensitive tests are required to ensure sustained virologic response (SVR), defined as undetectable HCV RNA following treatment.
- HCV testing that provides accurate results are simple to use and test volume flexibility can enhance HCV elimination programs.
La solución
- The Xpert HCV Viral Load test is designed for the rapid quantitation of Hepatitis C Virus (HCV) RNA in human serum or plasma (EDTA) from HCV-infected individuals.
- The Xpert HCV Viral Load test is intended to aid in the management of HCV infected patients undergoing antiviral therapy and can be utilized to predict sustained virological responses to HCV therapy as well as confirmation of HCV infection in anti-HCV positive individuals.
El impacto
- Aumente la eficiencia: Simplified workflow and on-demand testing reduces hands-on time1
- Mejore la atención al paciente: Fast results enable earlier adjustment to appropriate therapy2.3
- Enable testing in a range of laboratory settings. Flexible: Adaptable to meeting throughput requirements4
1 McHugh et al. Multicenter Evaluation of the Cepheid Xpert Hepatitis C Virus Viral Load Assay. J Clin Microbiol. 2017 May; 55(5):1550-1556. https://www.ncbi.nlm.nih.gov/pubmed/28275079
2 Shilton et al 2022, Feasibility and effectiveness of HCV viraemia testing at harm reduction sites in Georgia: A prospective threearm study. Liver Int. 2022 Apr; 42(4): 775–786
3 Thedja et al 2021, Improving Linkage to Care of Hepatitis C: Clinical Validation of GeneXpert® HCV Viral Load Point-of-Care Assay in Indonesia Am. J. Trop. Med. Hyg., 105(1), 2021, pp. 117–124
4 Gupta et al. Point -of -care testing (POCT) in molecular diagnostics: Performance evaluation of GeneXpert HCV RNA test in diagnosing and monitoring of HCV infection. J Clin Virol. 2017 Mar; 88:46-51.
2 Shilton et al 2022, Feasibility and effectiveness of HCV viraemia testing at harm reduction sites in Georgia: A prospective threearm study. Liver Int. 2022 Apr; 42(4): 775–786
3 Thedja et al 2021, Improving Linkage to Care of Hepatitis C: Clinical Validation of GeneXpert® HCV Viral Load Point-of-Care Assay in Indonesia Am. J. Trop. Med. Hyg., 105(1), 2021, pp. 117–124
4 Gupta et al. Point -of -care testing (POCT) in molecular diagnostics: Performance evaluation of GeneXpert HCV RNA test in diagnosing and monitoring of HCV infection. J Clin Virol. 2017 Mar; 88:46-51.
Productos relacionados
Xpert HCV VL Fingerstick
Detection and quantification of Hepatitis C virus (HCV) in about an hour
Xpert HBV Viral Load
Quantitation of Hepatitis B Virus (HBV) in less than one hour
Xpert HIV-1 Viral Load XC
Pruebas moleculares de nueva generación para la detección de la infección por VIH-1 y seguimiento de la carga viral
Xpert HIV-1 Qual XC
A molecular point-of-care test that delivers results in around 90 minutes